Five Johns Hopkins Physicians Inducted Into American Society For Clinical Investigation
Johns Hopkins' Mary Armanios, M.D.; L. Ebony Boulware, M.D., M.P.H.; Andrea Cox, M.D., Ph.D.; Kelly Gebo, M.D., M.P.H.; and Sherita Golden, M.D., M.H.S., have been inducted into the American Society for Clinical Investigation (ASCI). The five were among 80 new members inducted at the ASCI's annual meeting on April 26 in Chicago. Founded in 1908, ASCI is an honor society for physician-researchers.
"It's very exciting to see Johns Hopkins physician-scientists make such a strong showing among the new ASCI members this year. Membership in the society is a high honor, and is a tribute to the stellar work of each of our five new members," said Myron Weisfeldt, M.D., the William Osler Professor and director of the Department of Medicine.
About the inductees:
Mary Armanios is an associate professor of oncology at the Johns Hopkins Kimmel Cancer Center. She received her medical degree from the Ohio State University College of Medicine in 1996 and completed residencies at Ohio State in internal medicine and pediatrics. Her fellowship training in oncology was completed at the Johns Hopkins Kimmel Cancer Center, and she is board-certified in internal medicine and medical oncology.
Armanios' clinical and research interests focus on disorders caused by dysfunction in telomeres, the segments of DNA at the ends of chromosomes. Her group's goal is to define approaches to surveillance, diagnosis and treatment for patients with telomere-mediated disease. She directs the Telomere Clinic in the Sidney Kimmel Comprehensive Cancer Center, which provides multidisciplinary care to patients who are suspected to have or who carry the diagnosis of telomere-related disorders. These disorders include cancer, bone marrow failure/aplastic anemia, and lung disease, including idiopathic pulmonary fibrosis and liver cirrhosis, among others.
L. Ebony Boulware is a general internist and associate professor of medicine and epidemiology at The Johns Hopkins University. She received an A.B. degree in English from Vassar College, an M.D. from Duke University and an M.P.H. from the Johns Hopkins Bloomberg School of Public Health. Boulware studies interventions to improve patient care and clinical outcomes with chronic diseases such as chronic kidney disease (CKD) and hypertension. She is particularly interested in identifying ways to eliminate ethnic and racial disparities in these diseases. She has investigated several related areas in her research, including determinants of whether transplant patients are paired with deceased or live kidney donors, organ donation policies, patients' preferences for kidney transplants, patient-physician communication about kidney transplants, and the quality of primary and nephrology care for patients with kidney disease. She has developed and studied educational, behavioral and clinical practice interventions to improve patient, family and physician communication and decision-making regarding treatment of kidney disease and kidney disease risk factors.
Andrea Cox is an expert in treating people infected with the hepatitis C virus (HCV). She is an associate professor and the co-director of the Medical Scientist Training Program at the Johns Hopkins School of Medicine. Cox's research focuses on the host immune response to infection with HCV and HIV. The overall goal of Cox's research team is to determine how inflammation caused by HCV and HIV causes severe disease and to develop vaccines against HCV by finding out how HCV evades the body's immune response.
Kelly Gebo is an associate professor at the Johns Hopkins University School of Medicine, Bloomberg School of Public Health and Krieger School of Arts and Sciences. She is co-principal investigator of the HIV Research Network (HIVRN), a consortium of 18 high-volume HIV medical care clinics across the United States caring for more than 16,000 patients with HIV disease. Using data from HIVRN, she researches health disparities, access to care, health care utilization, errors in medicine and costs of care. She also performs clinical outcomes research in HIV-infected adolescents and the elderly. Gebo is also director of the undergraduate major in public health studies at Johns Hopkins, the largest major in the school of arts and sciences. She mentors numerous students on HIV research projects and teaches undergraduate and medical students how to do research through an honors seminar in public health and the clinical research track in the scholarly concentrations course in the school of medicine.
Sherita Golden is an associate professor of medicine in the Division of Endocrinology and also holds joint appointments in the Welch Center for Prevention, Epidemiology, and Clinical Research and in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She received a B.S. degree in biology from the University of Maryland, College Park; an M.D. from the University of Virginia; and an M.H.S. from the Johns Hopkins Bloomberg School of Public Health. Golden's primary research interest centers around identifying endocrine risk factors associated with development of diabetes and cardiovascular disease. She does this by incorporating hormonal function measures into the design of clinical trials of cardiovascular risk modification and by conducting observational studies of incident cardiovascular disease and diabetes and studies evaluating diabetic complications. Golden's research explores the role of hypothalamic-pituitary-adrenal (HPA) axis biomarkers in type 2 diabetes pathogenesis. She has demonstrated a bi-directional, longitudinal association between depression and type 2 diabetes and has made fundamental discoveries regarding hormonal determinants of this association. She is the principal investigator of the Diabetes Prevention Program Outcome Study at Johns Hopkins and in 2012 led the writing group of the Endocrine Society's first scientific statement on Disparities in Endocrine Disorders.